CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Non-Controlling Interest	Total
Balance at beginning of year at Dec. 31, 2022	$ 750	$ 342,664	$ (328,042)	$ (6,103)	$ 2,460	$ 11,729
Balance at beginning of year (in shares) at Dec. 31, 2022	75,020
Net income (loss)			(34,582)		15	(34,567)
Issuance of common shares related to acquisitions		446				446
Issuance of common shares related to acquisitions (in shares)	40
Issuance of common shares related to Public Warrant exercise	$ 2	3,142				3,144
Issuance of common shares related to Public Warrant exercise (in shares)	229
Issuance of common shares related to stock options exercised	$ 1	847				848
Issuance of common shares related to stock options exercised (in shares)	88
Issuance of common shares related to conversion of Series A Convertible Preferred Shares	$ 1	881				882
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares)	76
Issuance of common shares related to purchase of non-controlling interest	$ 1	474			$ (2,475)	(2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares)	100
Issuance of common shares, net of issuance costs	$ 119	117,648				117,767
Issuance of common shares, net of issuance costs (in shares)	11,877
Amortization of Series A Convertible Preferred Shares		(161)				(161)
Other comprehensive income (loss)				9,921		9,921
Equity-based compensation	$ 6	8,702				8,708
Equity-based compensation (in shares)	621
Net share settlement of equity awards		(2,977)				(2,977)
Balance at end of year at Dec. 31, 2023	$ 880	471,666	(362,624)	3,818		113,740
Balance at end of year (in shares) at Dec. 31, 2023	88,051
Net income (loss)			(80,298)			(80,298)
Issuance of common shares related to "at-the-market" offering program, net of issuance costs	$ 1	624				625
Issuance of common shares related to "at-the-market" offering program, net of issuance costs (in shares)	60
Issuance of common shares related to stock options exercised		12				12
Issuance of common shares related to stock options exercised (in shares)	1
Issuance of common shares related to warrant exchange	$ 54	37,732				37,786
Issuance of common shares related to warrant exchange (in shares)	5,539
Issuance of common shares related to conversion of Series A Convertible Preferred Shares		16				16
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares)	1
Amortization of Series A Convertible Preferred Shares		349				349
Other comprehensive income (loss)				15,766		15,766
Equity-based compensation	$ 7	11,601				11,608
Equity-based compensation (in shares)	569
Net share settlement of equity awards		(2,122)				(2,122)
Balance at end of year at Dec. 31, 2024	$ 942	519,878	(442,922)	19,584		97,482
Balance at end of year (in shares) at Dec. 31, 2024	94,221
Net income (loss)			(90,445)			(90,445)
Issuance of common shares related to "at-the-market" offering program, net of issuance costs	$ 19	11,896				11,915
Issuance of common shares related to "at-the-market" offering program, net of issuance costs (in shares)	1,910
Amortization of Series A Convertible Preferred Shares		347				347
Other comprehensive income (loss)				(33,621)		(33,621)
Equity-based compensation	$ 8	14,544				14,552
Equity-based compensation (in shares)	735
Net share settlement of equity awards		(2,098)				(2,098)
Other			(1,003)	1,003
Balance at end of year at Dec. 31, 2025	$ 969	$ 544,567	$ (534,370)	$ (13,034)		$ (1,868)
Balance at end of year (in shares) at Dec. 31, 2025	96,866